1. Ackenheil M (1993) Methodische Probleme bei molekulargenetischen Untersuchungen psychiatrischer Erkrankungen. Nervenheilkunde 12: 14–17
2. Ackenheil M, Bondy B (1996) The value of biological markers in genetic research. In: Mendlewicz J, Papadimitriou GN (eds) Clinical psychiatry. Mental disorders. Bailliere Tindall, London, pp 135–148
3. Antonarakis SE, Blouin J-L, Pulver AE, Wolyniec P, Kasseter VK, Nestadt G, Lasch L, Babb R, Kazazian HH, Dombrowski B, Kimberland M, Ott J, Housman D, Karayiorgou M, McLean CJ (1995) Letter to the Editor. Nature Genet 11: 235–236
4. Ashworth A, Abusaad I, Walsh C, Nanko S, Murray RM, Asherson P, McGuffin P, Gill M, Owen MJ, Collier DA (1996) Linkage analysis of the fragile X gene FMR-1 and schizophrenia: no evidence for linkage but report of a family with schizophrenia and an unstable triplet repeat. Psychiat Genet 6: 81–86
5. Badri F, Masellis M, Petroniss A, Macciardi FM, Van Tol HHM, Cola P, Meltzer HY, Lieberman J, Potkin S, Kennedy JL (1996) Dopamine and serotonin system genes may predict clinical response to clozapine. Am J Hum Genet 59 [Suppl]: 247